Anicetti Vincent R 4
4 · Coherus BioSciences, Inc. · Filed Jan 13, 2021
Insider Transaction Report
Form 4
Anicetti Vincent R
Chief, Quality & Compliance
Transactions
- Award
Common Stock
2021-01-11+31,250→ 59,739 total - Award
Stock Option (Right to Buy)
2021-01-11+62,500→ 62,500 totalExercise: $17.58Exp: 2031-01-11→ Common Stock (62,500 underlying)
Footnotes (3)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 11 of each year, with the first 1/3 vesting on January 11, 2022 and with the RSUs being fully vested on January 11, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F2]Includes 52,083 RSUs.
- [F3]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.